机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau SAR, China.[2]Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.[3]Department of Pulmonary and Critical Care Medicine, Chengdu Third People's Hospital Branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu, China.[4]Department of Pulmonary and Critical Care Medicine, Sichuan Friendship Hospital, Chengdu, China.
National Natural Science
Foundation of China (81970026, 82000029, and 82200079),
Natural Science Foundation of Sichuan (2022NSFCS1324),
Chengdu High-level Key Clinical Specialty Construction
Project (ZX20201202020), Chengdu Science and Technology
Bureau (2021-YF09-00102-SN and 2020-YF05-00003-SN),
Sichuan Medical Association (Q21061), and the Health
Commission of Chengdu (2022193 and 2022194).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|3 区生物学
小类|3 区遗传学
最新[2023]版:
大类|3 区生物学
小类|3 区遗传学
第一作者:
第一作者机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau SAR, China.[2]Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau SAR, China.[2]Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.[3]Department of Pulmonary and Critical Care Medicine, Chengdu Third People's Hospital Branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu, China.
推荐引用方式(GB/T 7714):
Zhu Dong,Liu Jiliu,Wang Junyi,et al.Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers[J].Frontiers in genetics.2022,13:1077615.doi:10.3389/fgene.2022.1077615.
APA:
Zhu Dong,Liu Jiliu,Wang Junyi,Zhang Lei,Jiang Manling...&Li Guoping.(2022).Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers.Frontiers in genetics,13,
MLA:
Zhu Dong,et al."Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers".Frontiers in genetics 13.(2022):1077615